SB
DGX icon

Strategic Blueprint’s Quest Diagnostics DGX Stock Holding History

Strategic Blueprint’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-405
Closed -$53K – 603
2021
Q2 		$53K Buy
+405
New +$53K 0.01% 600
2020
Q3 		– Sell
-13,695
Closed -$1.56M – 215
2020
Q2 		$1.56M Buy
+13,695
New +$1.45M 0.55% 55
2019
Q4 		– Sell
-217
Closed -$23K – 168
2019
Q3 		$23K Buy
+217
New +$22.3K 0.02% 219

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Strategic Blueprint's DGX Position: Q3 2021 in Review

Strategic Blueprint sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 405 shares — an estimated $53K sold.

Strategic Blueprint first reported a position in DGX in Q3 2019 and held it in 3 quarters. The position peaked at $1.56M in Q2 2020. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • Strategic Blueprint reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
  • Strategic Blueprint sold 405 Quest Diagnostics shares in Q3 2021, an estimated $53K.
  • Strategic Blueprint first reported a position in Quest Diagnostics in Q3 2019 and held it in 3 quarters.
  • Strategic Blueprint's Quest Diagnostics position peaked at $1.56M in Q2 2020.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.